Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

Similar articles for PubMed (Select 9109469)

1.

Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening.

Ridker PM, Miletich JP, Hennekens CH, Buring JE.

JAMA. 1997 Apr 23-30;277(16):1305-7.

PMID:
9109469
2.

Why is factor V Leiden so rare in the Basques?

Bauduer F.

J Thromb Haemost. 2015 May;13(5):697-8. doi: 10.1111/jth.12859. Epub 2015 Feb 20.

PMID:
25645287
3.

Haemostaseome-associated SNPs: has the thrombotic phenotype a greater influence than ethnicity? GMT study from Aquitaine including Basque individuals.

Freyburger G, Labrouche S, Hubert C, Bauduer F.

Thromb Haemost. 2015 Jan;113(1):66-76. doi: 10.1160/TH14-02-0189. Epub 2014 Nov 6.

PMID:
25374097
4.

Ischemic stroke in a patient with hetrozygous factor v leiden mutation: an uncommon association.

Ghalaut PS, Duhan J, Chaudhary V, Dahiya HK, Kaushik S, Sharma M, Pehalajani JK.

Indian J Hematol Blood Transfus. 2014 Sep;30(Suppl 1):335-7. doi: 10.1007/s12288-014-0392-2. Epub 2014 May 4. No abstract available.

PMID:
25332612
5.

Evaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population.

Karimi S, Yavarian M, Azinfar A, Rajaei M, Azizi Kootenaee M.

Iran J Reprod Med. 2012 Jan;10(1):59-66.

6.

Single nucleotide polymorphisms other than factor V Leiden are associated with coagulopathy and osteonecrosis of the femoral head in Chinese patients.

Peng KT, Huang KC, Huang TW, Lee YS, Hsu WH, Hsu RW, Ueng SW, Lee MS.

PLoS One. 2014 Aug 13;9(8):e104461. doi: 10.1371/journal.pone.0104461. eCollection 2014.

7.

[Idiopathic intracranial hypertension and factor V Leiden mutation].

Younes S, Aissi M, Chérif Y, Daoussi N, Boughammoura A, Frih Ayed M, Sfar MH, Jerbi S.

J Mal Vasc. 2014 Jul;39(4):270-3. doi: 10.1016/j.jmv.2014.04.012. Epub 2014 Jun 5. French.

PMID:
24908418
8.

Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type.

Sode BF, Allin KH, Dahl M, Gyntelberg F, Nordestgaard BG.

CMAJ. 2013 Mar 19;185(5):E229-37. doi: 10.1503/cmaj.121636. Epub 2013 Feb 4.

9.

Prevalence of coagulation factor II G20210A and factor V G1691A Leiden polymorphisms in Chechans, a genetically isolated population in Jordan.

Dajani R, Fatahallah R, Dajani A, Al-Shboul M, Khader Y.

Mol Biol Rep. 2012 Sep;39(9):9133-8. doi: 10.1007/s11033-012-1785-7. Epub 2012 Jun 29.

PMID:
22744422
10.
11.

An age-related decrease in factor V Leiden frequency among Polish subjects.

Adler G, Parczewski M, Czerska E, Loniewska B, Kaczmarczyk M, Gumprecht J, Grzeszczak W, Szybinska A, Mossakowska M, Ciechanowicz A.

J Appl Genet. 2010;51(3):337-41. doi: 10.1007/BF03208864.

PMID:
20720309
12.

Family history of venous thromboembolism and identifying factor V Leiden carriers during pregnancy.

Horton AL, Momirova V, Dizon-Townson D, Wenstrom K, Wendel G, Samuels P, Sibai B, Spong CY, Cotroneo M, Sorokin Y, Miodovnik M, O'Sullivan MJ, Conway D, Wapner RJ; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU).

Obstet Gynecol. 2010 Mar;115(3):521-5. doi: 10.1097/AOG.0b013e3181d018a8.

13.

AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.

Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.

Haematologica. 2008 May;93(5):729-34. doi: 10.3324/haematol.12271. Epub 2008 Apr 2.

14.

Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.

Rahimi Z, Vaisi-Raygani A, Nagel RL, Muniz A.

J Thromb Thrombolysis. 2008 Jun;25(3):288-92. Epub 2007 Jul 11.

PMID:
17619828
16.

Racial differences in the prevalence of Factor V Leiden mutation among patients on chronic warfarin therapy.

Limdi NA, Beasley TM, Allison DB, Rivers CA, Acton RT.

Blood Cells Mol Dis. 2006 Sep-Oct;37(2):100-6. Epub 2006 Aug 2.

17.

Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism.

Jun ZJ, Ping T, Lei Y, Li L, Ming SY, Jing W.

Clin Lab Haematol. 2006 Apr;28(2):111-6.

PMID:
16630215
18.

Interaction between factor V Leiden and serum LDL cholesterol increases the risk of atherosclerosis.

Völzke H, Wolff B, Grimm R, Robinson DM, Schuster G, Herrmann FH, Motz W, Rettig R.

Atherosclerosis. 2005 Jun;180(2):341-7. Epub 2005 Jan 19.

PMID:
15910861
19.

The factor V leiden mutation and the risk of venous thromboembolism in gynecologic oncology patients1.

Ravin AJ, Edwards RP, A Krohn M, Kelley JR, Christopherson WA, Roberts JM.

Obstet Gynecol. 2002 Dec;100(6):1285-9.

PMID:
12468175
20.

Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.

Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY.

Am J Hematol. 2002 Dec;71(4):300-5.

PMID:
12447960
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk